Cell Line, TumorCisplatinColorectal Neoplasms
Dr. Michael Foote, MD
NPI1659794709PAC ID2860788775
- Medicare services, 2024
- 271
- Medicare patients, 2024
- 81
- Part D claims, 2024
- 239
- Publications
- 45
- MIPS score, 2024
- 76
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Foote's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Foote is a medical oncologist in New York, New York
Dr. Foote practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Foote's NPI, 1659794709, was assigned on January 27, 2014. Dr. Foote graduated from Johns Hopkins University School of Medicine in 2016. Dr. Foote holds New York license 297623-01.
NPI and contact details
- NPI
- 1659794709NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2860788775
- NPI enumeration date
- January 27, 2014
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 36
- Medical school graduation
- 2016
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael Foote practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Foote's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Michael Foote is affiliated with 4 sites of care and 3 medical groups
Dr. Foote's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Foote to 3 more group practices and clinics and 2 medical groups, each named with a free account.
Memorial Sloan Kettering Cancer Center3 group practices and clinicsNames with a free account2 medical groupsNames with a free account
See all 7 affiliations for Dr. FooteSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael Foote's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foote practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Foote practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Foote is one of 458 medical oncologists in New York
Medical oncology is Dr. Foote's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Foote is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Foote
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
458medical oncologists in New York330medical oncologists in New York141medical oncologists at Memorial Sloan Kettering Cancer Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Foote billed Medicare for 271 services in 2024
CMS data shows 271 Medicare services from Dr. Foote across 2 procedure codes in 2024, all of them office visits, for 81 Medicare patients. Medicare paid $24,311 for them. Every service was in an office.
Medicare services, 2024271
Medicare patients81
Paid by Medicare$24,311
Procedure codes2
Dr. Foote's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4352024: 27138%
Dr. Foote compared with the New York median for medical oncologists, 2024
- Dr. Foote
- New York median
- Medicare services
- 271vs 34020% below
- Medicare patients
- 81vs 11228% below
- Part D claims
- 142vs 1309% above
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Foote's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Foote?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Foote and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael Foote treated 81 Medicare patients in 2024, average age 75
CMS counts 81 Medicare patients who saw Dr. Foote in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Foote's median patient age at 70, with 47% women.
Medicare patients, 202481
Average age75
Average risk score2.68
Dr. Foote's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Foote's Medicare patients by sex, 2024
- Women4151%
- Men4049%
Chronic conditions among Dr. Foote's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol72%
- Arthritis46%
- Anxiety37%
- Diabetes32%
- Ischemic heart disease27%
- Chronic kidney disease26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Foote's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women47%
- Men50%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Michael Foote wrote 239 Medicare Part D claims in 2024
In 2024, Dr. Foote wrote 239 Medicare Part D claims for 54 patients. 80% of them were for generic drugs. CMS names the drug for 142 of them, across 7 drugs with 11 or more claims each, at $18,033 in total drug cost. In 2023, CMS named 137 claims across 7 drugs.
Part D claims, 2024239
Drugs named by CMS7
Total drug cost$18,033
Part D patients54
Dr. Foote's Part D claims by kind of drug, 2024
- Generic191 claims80%
- Brand-name48 claims20%
Dr. Foote's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Foote's Part D claims, 2024
- Opioids6%14 of 239 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1372024: 1424%
Drugs named by CMS: 7 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Michael Foote scored 76 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Foote for performance year 2024, reported as part of a group. Dr. Foote accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Foote as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Foote's MIPS scores, performance year 2024
- 76of 100Final score
- 60.6of 100Quality
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Foote by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Foote has 45 publications on record
Dmand AI links 45 papers to Dr. Foote, published from 2011 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Cell Line, Tumor, Colorectal Neoplasms and Adenocarcinoma. Dr. Foote has published most often in J Clin Oncol. Dr. Foote's most frequent co-authors are Luis Alberto Diaz, MD, Steven Maron, MD and Steven B. Maron, MD.
Papers45
Years published2011 to 2025
Dr. Foote's papers by year, 2014 to 2025
Topics Dr. Foote writes about most
- Cell Line, Tumor
- Colorectal Neoplasms
- Adenocarcinoma
- Biomarkers, Tumor
- COVID-19
- DNA Mismatch Repair
- Immunotherapy
- Programmed Cell Death 1 Receptor
Dr. Foote's most frequent co-authors
- Luis Alberto Diaz, MD8 shared papers
- Steven Maron, MD8 shared papers
- Steven B. Maron, MD6 shared papers
Recent publications by Dr. Foote
Antibodies, Monoclonal, HumanizedCapecitabineChemoradiotherapy, Adjuvant
AdenosineGene Expression Regulation, Neoplastic
Gynecol Oncol
Antibodies, Monoclonal, HumanizedCystadenocarcinoma, SerousDrug Resistance, Neoplasm
Drug Delivery SystemsImmune Checkpoint InhibitorsImmunotherapy
See who Dr. Foote researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Foote works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Foote received $4,026 in industry payments from 2022 to 2025
CMS Open Payments shows 3 general payments to Dr. Foote from 3 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $3,880.
General payments to Dr. Foote by program year, 2022 to 2025
General payments to Dr. Foote by kind, 2022 to 2025
$4Kin total
- Consulting fees$4,00599%
- Food and beverage$211%
Companies that paid Dr. Foote the most, 2022 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael Foote graduated from Johns Hopkins University School of Medicine
Dr. Foote graduated from Johns Hopkins University School of Medicine in 2016.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael Foote's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Foote
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Foote's NPI number?
Dr. Michael Foote's NPI number is 1659794709. It was assigned on January 27, 2014, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Foote?
Dr. Michael Foote is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Michael Foote practice?
Dr. Foote practices at 1275 York Avenue, New York, NY 10065. Dr. Foote's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Foote to 3 group practices and clinics and 2 medical groups.
What is Dr. Michael Foote's medical license number?
Dr. Foote holds New York license 297623-01.
Which hospitals is Dr. Michael Foote affiliated with?
Dr. Foote practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Michael Foote part of?
Dr. Foote is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Foote to 2 more medical groups.
Does Dr. Michael Foote accept Medicare?
Yes. CMS data shows Dr. Foote billed Medicare for 271 services in 2024, and Dr. Foote accepts Medicare assignment.
Does Dr. Michael Foote offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Foote as offering telehealth services.
What is Dr. Michael Foote's MIPS score?
Dr. Foote's MIPS final score for performance year 2024 is 76 out of 100, reported as part of a group.
How many Medicare patients does Dr. Michael Foote see?
CMS counts 81 Medicare patients who saw Dr. Foote in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Michael Foote bill to Medicare?
In 2024, Dr. Foote's most billed Medicare services were office visit, established patient (99214) and office visit, new patient (99205).
Where did Dr. Michael Foote go to medical school?
Dr. Foote graduated from Johns Hopkins University School of Medicine in 2016.
What drugs does Dr. Michael Foote prescribe most?
In 2024 Medicare Part D data, Dr. Foote's most prescribed drugs by claims were Pantoprazole Sodium, Eliquis and Ondansetron HCl.
Has Dr. Michael Foote received payments from drug or device companies?
CMS Open Payments shows $4,026 in general payments to Dr. Foote from 3 companies from 2022 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Michael Foote been practicing?
Dr. Foote graduated from medical school in 2016, 10 years ago.
Does Dr. Michael Foote do research?
Dmand AI links 45 publications to Dr. Foote, published from 2011 to 2025.
Who does Dr. Michael Foote publish with?
Dr. Foote's most frequent co-authors are Luis Alberto Diaz, MD (8 shared papers), Steven Maron, MD (8 shared papers) and Steven B. Maron, MD (6 shared papers).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card